Design and Endpoints of Clinical Trials in Hepatocellular CarcinomaJosep M. Llovet, Gregory J. Gores, Adrian M. Di Bisceglie et al.|JNCI Journal of the National Cancer Institute|2008Cited by 1.7k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without CirrhosisKris V. Kowdley, Michael Fried, Robert H. Hyland et al.|New England Journal of Medicine|2014Cited by 1.1k
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†W. Ray Kim, Henry C. Bodenheimer, Steven L. Flamm et al.|Hepatology|2008Cited by 865
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayMarlyn J. Mayo, William Rosenberg, Julie Parkes et al.|Hepatology|2008Cited by 199
Hepatitis C virus antigen in hepatocytes: Immunomorphologic detection and identificationK. Krawczyński, Miriam J. Alter, Michael J. Beach et al.|Gastroenterology|1992Cited by 154